We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.37%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.4B
AUM Growth
-$234M
(-0.62%)
Cap. Flow
-$832M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
2,051
New
47
Increased
483
Reduced
1,317
Closed
203
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$240M |
| 2 |
Sysco
SYY
|
+$180M |
| 3 |
Synopsys
SNPS
|
+$83.9M |
| 4 |
C.H. Robinson
CHRW
|
+$42.1M |
| 5 |
United Bankshares
UBSI
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$216M |
| 2 |
Apple
AAPL
|
+$189M |
| 3 |
Microsoft
MSFT
|
+$115M |
| 4 |
Meta Platforms (Facebook)
META
|
+$68.7M |
| 5 |
Broadcom
AVGO
|
+$65.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.13% |
| 2 | Consumer Staples | 11.3% |
| 3 | Industrials | 10.65% |
| 4 | Financials | 9.24% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Harmony Biosciences
HRMY
$2.04B
| $255K | ﹤0.01% |
8,459
-2,029
| -19% | -$61K |
|
1402
ESAB
ESAB
$5.25B
| $253K | ﹤0.01% |
2,678
-87
| -3% | -$9.04K |
|
1403
Pebblebrook Hotel Trust
PEB
$2.16B
| $252K | ﹤0.01% |
18,343
-5,671
| -24% | -$82.5K |
|
1404
Genpact
G
$5.3B
| $251K | ﹤0.01% |
7,809
-248
| -3% | -$8K |
|
|
HCP
1405
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $251K | ﹤0.01% |
+7,440
| New | +$231K |
|
1406
Shoals Technologies Group
SHLS
$1.58B
| $250K | ﹤0.01% |
40,046
-1,005
| -2% | -$8.02K |
|
1407
Roblox
RBLX
$34B
| $249K | ﹤0.01% |
6,697
+1,206
| +22% | +$42.9K |
|
1408
Macy's
M
$6.15B
| $249K | ﹤0.01% |
12,976
-394
| -3% | -$7.53K |
|
1409
La-Z-Boy
LZB
$1.59B
| $249K | ﹤0.01% |
6,670
-2,072
| -24% | -$73.1K |
|
1410
Sprout Social
SPT
$455M
| $249K | ﹤0.01% |
6,968
-2,619
| -27% | -$105K |
|
|
NVEI
1411
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $248K | ﹤0.01% |
+7,670
| New | +$247K |
|
1412
Gentherm
THRM
$1.31B
| $248K | ﹤0.01% |
5,025
-1,585
| -24% | -$81.9K |
|
1413
Louisiana-Pacific
LPX
$5.2B
| $248K | ﹤0.01% |
3,008
-122
| -4% | -$10.2K |
|
1414
Post Holdings
POST
$4.12B
| $247K | ﹤0.01% |
2,372
-85
| -3% | -$8.85K |
|
1415
Recursion Pharmaceuticals
RXRX
$1.57B
| $247K | ﹤0.01% |
32,877
-8,072
| -20% | -$70.4K |
|
1416
Tronox
TROX
$995M
| $246K | ﹤0.01% |
15,692
-5,357
| -25% | -$97.4K |
|
1417
Huron Consulting
HURN
$1.82B
| $245K | ﹤0.01% |
2,491
-851
| -25% | -$78.3K |
|
1418
Timken Company
TKR
$9.82B
| $245K | ﹤0.01% |
3,055
-113
| -4% | -$9.75K |
|
1419
FuboTV Inc
FUBO
$245M
| $244K | ﹤0.01% |
16,420
+6,837
| +71% | +$109K |
|
1420
Nexstar Media Group
NXST
$5.6B
| $244K | ﹤0.01% |
1,471
-101
| -6% | -$16.4K |
|
|
GAP
1421
The Gap Inc
GAP
$6.84B
| $244K | ﹤0.01% |
10,216
-277
| -3% | -$6.44K |
|
|
AVDX
1422
DELISTED
AvidXchange
AVDX
| $244K | ﹤0.01% |
20,230
-6,905
| -25% | -$78.8K |
|
1423
Dentsply Sirona
XRAY
$2.59B
| $244K | ﹤0.01% |
9,792
-18,805
| -66% | -$539K |
|
1424
Dana Inc
DAN
$2.91B
| $243K | ﹤0.01% |
20,052
-6,199
| -24% | -$80.6K |
|
1425
Edgewise Therapeutics
EWTX
$4.39B
| $243K | ﹤0.01% |
13,490
-3,395
| -20% | -$59.2K |
|
Similar funds
ProShare Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, ProShare Advisors held 2,051 positions worth $37.4B, down 0.62% from $37.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
ProShare Advisors's Q2 2024 filing shows 47 new, 483 increased, 1,317 reduced and 203 closed positions. Its largest new stake was KKR & Co: 135,149 shares worth $14.2M. The largest sale was 3M, an estimated $216M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q2 2024 buy was KKR & Co: 135,149 shares worth $14.2M.
- ProShare Advisors added most to Qualcomm in Q2 2024, an estimated $240M increase.
- ProShare Advisors's biggest Q2 2024 reduction was 3M, cutting an estimated $216M.
- ProShare Advisors fully exited Leggett & Platt in Q2 2024, selling an estimated $24.6M.
- ProShare Advisors's ten largest holdings make up 26% of its $37.4B portfolio in Q2 2024.
- ProShare Advisors opened 47 new positions and closed 203 in Q2 2024.
- ProShare Advisors's portfolio value fell 0.62% quarter-over-quarter to $37.4B.
Based on ProShare Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.